Clinical Trial Update: Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of bortezomib and mycophenolate in interstitial lung disease associated with systemic sclerosis (scleroderma); study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Scleroderma
• Systemic Sclerosis

Drugs mentioned

• Bortezomib (bortezomib)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Northwestern University | Conditions: Lung Diseases, Interstitial, Systemic Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2021-08-25